バイオディフェンスの世界市場 2024-2028

バイオディフェンス市場は2023-2028年に71億6,134万米ドル、予測期間中のCAGRは-4.96%と予測されています。

当レポートでは、バイオディフェンス市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。生物製剤による脅威の増大、バイオテロの脅威の高まり、感染症の影響に対する一般市民の意識の高まりが市場を牽引しています。

本調査では、今後数年間のバイオディフェンス市場の成長を促進する主な要因の1つとして、市場参入企業間の製品発売や戦略的提携の増加を挙げています。また、有利な政府のイニシアチブ、世界化、より良いイミグレーションを必要とする旅行の増加は、市場の大規模な需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• バイオディフェンスの世界市場 2018-2022
• タイプ別セグメント分析 2018-2022
• 用途別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメンテーション
• 比較：タイプ別
• ワクチン：市場規模と予測 2023-2028
• 薬物：市場規模と予測 2023-2028
• 市場機会：タイプ別

第7章 市場セグメンテーション：用途別

• 市場セグメンテーション
• 比較：用途別
• COVID-19（新型コロナウイルス感染症）：市場規模と予測 2023-2028
• 炭疽菌：市場規模と予測 2023-2028
• 天然痘：市場規模と予測 2023-2028
• ボツリヌス中毒：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：用途別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• アジア：市場規模と予測 2023-2028
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• インド：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Alnylam Pharmaceuticals Inc.
• Appili Therapeutics Inc.
• AstraZeneca PLC
• Bavarian Nordic AS
• Chimerix Inc.
• Dynavax Technologies Corp.
• Elusys Therapeutics Inc.
• Emergent BioSolutions Inc.
• GlaxoSmithKline Plc
• Johnson and Johnson
• Novavax Inc.
• Sanofi SA
• SIGA Technologies Inc.
• Soligenix Inc.
• Tonix Pharmaceuticals Holding Corp.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary €" Chart on Market Overview
• Exhibits2: Executive Summary €" Data Table on Market Overview
• Exhibits3: Executive Summary €" Chart on Global Market Characteristics
• Exhibits4: Executive Summary €" Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary €" Chart on Market Segmentation by Type
• Exhibits6: Executive Summary €" Chart on Market Segmentation by Application
• Exhibits7: Executive Summary €" Chart on Incremental Growth
• Exhibits8: Executive Summary €" Data Table on Incremental Growth
• Exhibits9: Executive Summary €" Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size €" Data Table on global biodefense market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size €" Type Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size €" Application Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size €" Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size €" Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers €" Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers €" Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants €" Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes €" Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry €" Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Drugs - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Drugs - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Type ($ million)
• Exhibits43: Data Table on Market opportunity by Type ($ million)
• Exhibits44: Chart on Application - Market share 2023-2028 (%)
• Exhibits45: Data Table on Application - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by Application
• Exhibits47: Data Table on Comparison by Application
• Exhibits48: Chart on COVID 19 - Market size and forecast 2023-2028 ($ million)
• Exhibits49: Data Table on COVID 19 - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Chart on COVID 19 - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on COVID 19 - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Anthrax - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Anthrax - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Anthrax - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Anthrax - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Smallpox - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Smallpox - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Smallpox - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Smallpox - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Botulism - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Botulism - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Botulism - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Botulism - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits68: Market opportunity by Application ($ million)
• Exhibits69: Data Table on Market opportunity by Application ($ million)
• Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits73: Chart on Geographic comparison
• Exhibits74: Data Table on Geographic comparison
• Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on India - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits108: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits109: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits111: Market opportunity By Geographical Landscape ($ million)
• Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits113: Impact of drivers and challenges in 2023 and 2028
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: Alnylam Pharmaceuticals Inc. - Overview
• Exhibits120: Alnylam Pharmaceuticals Inc. - Product / Service
• Exhibits121: Alnylam Pharmaceuticals Inc. - Key offerings
• Exhibits122: Appili Therapeutics Inc. - Overview
• Exhibits123: Appili Therapeutics Inc. - Product / Service
• Exhibits124: Appili Therapeutics Inc. - Key offerings
• Exhibits125: AstraZeneca PLC - Overview
• Exhibits126: AstraZeneca PLC - Product / Service
• Exhibits127: AstraZeneca PLC - Key news
• Exhibits128: AstraZeneca PLC - Key offerings
• Exhibits129: Bavarian Nordic AS - Overview
• Exhibits130: Bavarian Nordic AS - Product / Service
• Exhibits131: Bavarian Nordic AS - Key offerings
• Exhibits132: Chimerix Inc. - Overview
• Exhibits133: Chimerix Inc. - Product / Service
• Exhibits134: Chimerix Inc. - Key offerings
• Exhibits135: Dynavax Technologies Corp. - Overview
• Exhibits136: Dynavax Technologies Corp. - Product / Service
• Exhibits137: Dynavax Technologies Corp. - Key offerings
• Exhibits138: Elusys Therapeutics Inc. - Overview
• Exhibits139: Elusys Therapeutics Inc. - Product / Service
• Exhibits140: Elusys Therapeutics Inc. - Key offerings
• Exhibits141: Emergent BioSolutions Inc. - Overview
• Exhibits142: Emergent BioSolutions Inc. - Product / Service
• Exhibits143: Emergent BioSolutions Inc. - Key news
• Exhibits144: Emergent BioSolutions Inc. - Key offerings
• Exhibits145: GlaxoSmithKline Plc - Overview
• Exhibits146: GlaxoSmithKline Plc - Business segments
• Exhibits147: GlaxoSmithKline Plc - Key news
• Exhibits148: GlaxoSmithKline Plc - Key offerings
• Exhibits149: GlaxoSmithKline Plc - Segment focus
• Exhibits150: Johnson and Johnson - Overview
• Exhibits151: Johnson and Johnson - Business segments
• Exhibits152: Johnson and Johnson - Key news
• Exhibits153: Johnson and Johnson - Key offerings
• Exhibits154: Johnson and Johnson - Segment focus
• Exhibits155: Novavax Inc. - Overview
• Exhibits156: Novavax Inc. - Product / Service
• Exhibits157: Novavax Inc. - Key offerings
• Exhibits158: Sanofi SA - Overview
• Exhibits159: Sanofi SA - Business segments
• Exhibits160: Sanofi SA - Key news
• Exhibits161: Sanofi SA - Key offerings
• Exhibits162: Sanofi SA - Segment focus
• Exhibits163: SIGA Technologies Inc. - Overview
• Exhibits164: SIGA Technologies Inc. - Product / Service
• Exhibits165: SIGA Technologies Inc. - Key offerings
• Exhibits166: Soligenix Inc. - Overview
• Exhibits167: Soligenix Inc. - Business segments
• Exhibits168: Soligenix Inc. - Key offerings
• Exhibits169: Soligenix Inc. - Segment focus
• Exhibits170: Tonix Pharmaceuticals Holding Corp. - Overview
• Exhibits171: Tonix Pharmaceuticals Holding Corp. - Product / Service
• Exhibits172: Tonix Pharmaceuticals Holding Corp. - Key offerings
• Exhibits173: Inclusions checklist
• Exhibits174: Exclusions checklist
• Exhibits175: Currency conversion rates for US$
• Exhibits176: Research methodology
• Exhibits177: Validation techniques employed for market sizing
• Exhibits178: Information sources
• Exhibits179: List of abbreviations

The biodefense market is forecasted to grow by USD -7161.34 million during 2023-2028, accelerating at a CAGR of -4.96% during the forecast period. The report on the biodefense market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing threat posed by biological agents, rising threat of bioterrorism, and growing public awareness of impact of infectious diseases.

Technavio's biodefense market is segmented as below:

By Type

• Vaccines
• Drugs

By Application

• COVID 19
• Anthrax
• Smallpox
• Botulism
• Others

By Geographical Landscape

• Asia
• North America
• Europe
• Rest of World (ROW)

This study identifies the rising product launches and strategic alliances among market participants as one of the prime reasons driving the biodefense market growth during the next few years. Also, favorable government initiatives and globalization and increased travel requiring better immuity will lead to sizable demand in the market.

The report on the biodefense market covers the following areas:

• Biodefense market sizing
• Biodefense market forecast
• Biodefense market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biodefense market vendors that include Alnylam Pharmaceuticals Inc., Appili Therapeutics Inc., AstraZeneca PLC, Bavarian Nordic AS, Chimerix Inc., Dynavax Technologies Corp., Elusys Therapeutics Inc., Emergent BioSolutions Inc., GlaxoSmithKline PLC, Merck and Co. Inc., Neogen Corp., Novavax Inc., Porton Biopharma Ltd., Sanofi SA, Serum Institute of India Pvt. Ltd., SIGA Technologies Inc., Soligenix Inc., Tonix Pharmaceuticals Holding Corp., Zoetis Inc., and Johnson and Johnson. Also, the biodefense market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global biodefense market 2018 - 2022
• 4.2 Type Segment Analysis 2018 - 2022
• 4.3 Application Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Type

• 6.1 Market segments
• 6.2 Comparison by Type
• 6.3 Vaccines - Market size and forecast 2023-2028
• 6.4 Drugs - Market size and forecast 2023-2028
• 6.5 Market opportunity by Type

7 Market Segmentation by Application

• 7.1 Market segments
• 7.2 Comparison by Application
• 7.3 COVID 19 - Market size and forecast 2023-2028
• 7.4 Anthrax - Market size and forecast 2023-2028
• 7.5 Smallpox - Market size and forecast 2023-2028
• 7.6 Botulism - Market size and forecast 2023-2028
• 7.7 Others - Market size and forecast 2023-2028
• 7.8 Market opportunity by Application

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 Asia - Market size and forecast 2023-2028
• 9.4 North America - Market size and forecast 2023-2028
• 9.5 Europe - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 China - Market size and forecast 2023-2028
• 9.9 India - Market size and forecast 2023-2028
• 9.10 UK - Market size and forecast 2023-2028
• 9.11 Germany - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Alnylam Pharmaceuticals Inc.
• 12.4 Appili Therapeutics Inc.
• 12.5 AstraZeneca PLC
• 12.6 Bavarian Nordic AS
• 12.7 Chimerix Inc.
• 12.8 Dynavax Technologies Corp.
• 12.9 Elusys Therapeutics Inc.
• 12.10 Emergent BioSolutions Inc.
• 12.11 GlaxoSmithKline Plc
• 12.12 Johnson and Johnson
• 12.13 Novavax Inc.
• 12.14 Sanofi SA
• 12.15 SIGA Technologies Inc.
• 12.16 Soligenix Inc.
• 12.17 Tonix Pharmaceuticals Holding Corp.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations